STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 74 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $10,000 | -94.1% | 2,172 | -86.7% | 0.00% | – |
| Q3 2019 | $170,000 | +226.9% | 16,334 | +375.1% | 0.00% | – |
| Q2 2019 | $52,000 | -60.0% | 3,438 | -66.2% | 0.00% | – |
| Q1 2019 | $130,000 | -62.2% | 10,167 | -72.0% | 0.00% | -100.0% |
| Q4 2018 | $344,000 | +124.8% | 36,307 | +291.7% | 0.00% | – |
| Q3 2018 | $153,000 | +36.6% | 9,270 | +31.7% | 0.00% | – |
| Q2 2018 | $112,000 | -33.3% | 7,038 | -36.0% | 0.00% | -100.0% |
| Q1 2018 | $168,000 | +25.4% | 10,994 | +27.9% | 0.01% | +16.7% |
| Q4 2017 | $134,000 | +28.8% | 8,594 | -8.9% | 0.01% | +50.0% |
| Q3 2017 | $104,000 | +225.0% | 9,436 | +165.2% | 0.00% | +300.0% |
| Q2 2017 | $32,000 | -47.5% | 3,558 | -50.3% | 0.00% | -66.7% |
| Q1 2017 | $61,000 | +771.4% | 7,155 | +966.3% | 0.00% | – |
| Q3 2016 | $7,000 | -84.8% | 671 | -93.2% | 0.00% | -100.0% |
| Q1 2016 | $46,000 | – | 9,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |